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Abstract
Bone loss with aging and menopause may be linked to vascular endothelial dysfunction. The purpose of the study was to
determine whether putative modifications in endothelium-dependent vasodilation of the principal nutrient artery (PNA) of
the femur are associated with changes in trabecular bone volume (BV/TV) with altered estrogen status in young (6 mon) and
old (24 mon) female Fischer-344 rats. Animals were divided into 6 groups: 1) young intact, 2) old intact, 3) young
ovariectomized (OVX), 4) old OVX, 5) young OVX plus estrogen replacement (OVX+E2), and 6) old OVX+E2. PNA
endothelium-dependent vasodilation was assessed in vitro using acetylcholine. Trabecular bone volume of the distal
femoral metaphysis was determined by microCT. In young rats, vasodilation was diminished by OVX and restored with
estrogen replacement (intact, 8267; OVX, 6169; OVX+E2, 9064%), which corresponded with similar modifications in BV/TV
(intact, 28.761.6; OVX, 16.360.9; OVX+E2, 25.761.4%). In old animals, vasodilation was unaffected by OVX but enhanced
with estrogen replacement (intact, 5568; OVX, 5967; OVX+E2, 9264%). Likewise, modifications in BV/TV followed the same
pattern (intact, 33.161.6; OVX, 34.463.7; OVX+E2, 42.462.1%). Furthermore, in old animals with low endogenous estrogen
(i.e., intact and old OVX), vasodilation was correlated with BV/TV (R2 = 0.630; P,0.001). These data demonstrate parallel
effects of estrogen on vascular endothelial function and BV/TV, and provide for a possible coupling mechanism linking
endothelium-dependent vasodilation to bone remodeling.
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Introduction
Postmenopausal osteoporosis is characterized by pronounced
bone resorption. A clear link between estrogen deficiency and
reduced bone mass is evident by the increased prevalence of
osteoporosis in women vs. men [1] and the direct association
between circulating estrogen levels and rates of bone loss [2–5]. In
addition, estrogen replacement serves to protect against skeletal
fractures and loss of bone [6] primarily by inhibiting bone
resorption [7]. The preponderance of literature examining the
effects of estrogen status and bone remodeling has attributed the
association to the direct effects of estrogen on bone cell activity.
However, there are other possible mechanisms whereby postmen-
opausal bone loss may be influenced and modulated.
There is increasing evidence in the literature that the osseous
vasculature influences bone remodeling. For example, vascular
endothelial cells release factors such as nitric oxide (NO) and
prostacyclin (PGI2) that are known to modulate osteoclast and
osteoblast activity [8–11]. In addition, the osseous resistance
vasculature regulates skeletal perfusion and, consequently, fluid
filtration and interstitial fluid flow, which can affect bone cell
activity through release of autocrine/paracine factors [12–17].
Dysfunction of these vascular mechanisms could therefore
contribute to postmenopausal and old age-related osteoporosis.
Indeed, attenuated bone and marrow blood flow has been
reported in healthy humans (.60 years of age) [18,19], senescent
rats [20–22] and rabbits [23] and is associated with osteopenia
[24]. Old age-related decrements in skeletal perfusion also
correspond with diminished endothelium-dependent vasodilation
of the femoral principal nutrient artery (PNA), reduced vascular
NO bioavailability, and diminished trabecular bone volume and
material properties of the femur in male rats [20–22]. Thus, aging
and estrogen loss may contribute to enhanced bone turnover in
females through impairment of endothelial responsiveness in the
skeletal circulation.
The purpose of the present study was to determine whether
estrogen status affects endothelium-dependent vasodilation in
bone blood vessels, and whether this is associated with changes
in trabecular bone volume. Estrogen levels were modified in young
and old female rats through ovariectomy and estrogen replace-
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ment. We hypothesized that the lower estrogen levels in old intact
and young and old ovariectomized (OVX) rats would be
associated with lower femoral PNA endothelium-dependent
vasodilation, and that estrogen replacement in young and old
OVX rats would enhance PNA endothelium-dependent vasodila-
tion through a NO signaling pathway. Furthermore, we hypoth-
esized that PNA endothelial vasodilator function would be directly
associated with trabecular bone volume.
Materials and Methods
Ethical Approval
The procedures used in this study were approved by the
University of Florida and West Virginia University School of
Medicine Institutional Animal Care and Use Committees and
conform to the Guide for the Care and Use of Laboratory Animals
published by the National Institutes of Health (NIH Publication
No. 85-23, revised 1996).
Young (4 mon old) and old (22 mon old) virgin female Fischer-
344 rats were obtained from the vendor (National Institute of
Aging colony, Harlan, Indianapolis, IN) and divided into six
groups: 1) young intact (n=10), 2) old intact (n=11), 3) young
OVX (n=10), 4) old OVX (n=9), 5) young OVX+E2 (n=11),
and 6) old OVX+E2 (n=10). After arrival all animals were housed
for an additional 8 weeks in a temperature-controlled (2362uC)
room with a 12:12 h light dark cycle. Rats in the latter four groups
underwent ovariectomy surgery and were housed post-operatively
for 8 weeks. Thus, at the time of sacrifice young animals were at
least 6 months of age and old rats were at least 24 months of age.
At 6 months of old, Fischer-344 rats are considered sexually-
mature young adults, and at 24 months of age are considered
senescent when mortality rates are $30% [25]. To control for the
levels of exogenous estrogen, all rats were provided with a
phytoestrogen-free diet and tap water ad libitum. Prior to sacrifice,
at least two complete estrous cycles were monitored in all female
rats by daily vaginal smears. At the time of sacrifice, 3 ml of blood
was collected in chilled tubes containing dipotassium EDTA.
Blood samples were centrifuged at 10,000 rpm at 4uC for 5 min,
and the plasma was collected and stored at 280uC for later
analysis. The ovaries (in intact females), uterus and cervix were
dissected and trimmed of connective tissue and fat to obtain
uterine mass. Plasma estrogen was determined with ELISA
immunoassay (Estradiol EIA kit, Oxford Biomedical; Oxford,
MI). Rats were sacrificed at 6 and 24 months of age.
Surgical Procedures
To examine the influence of circulating estrogen on the
vasomotor properties of the femoral PNA, the rats were
anesthetized with isoflurane (2%/oxygen balance) and subjected
to bi-lateral ovariectomy according to standard procedures as
described previously [26,27]. Briefly, bilateral dorsolateral inci-
sions were made through the top layer of skin. The underlying
muscles were bluntly dissected until the ovary and fallopian tube
were located. For rats in the OVX groups, the fallopian tube was
ligated with absorbable suture and the ovary was removed. Once
the surrounding fat pad was replaced within the abdominal cavity,
the musculature and outer layer of skin was sutured. Estrogen
replacement in the OVX+E2 groups was performed simultaneous
to the OVX procedure. Two 0.05 mg 17beta-estradiol 60-day
slow release pellets (Innovative Research) were implanted subcu-
taneously near the scapulae.
In Vitro PNA Studies
Rats were anesthetized (isoflurane 5%/O2 balance) and
euthanized by removing the heart. To assess endothelium-
dependent vasodilation of the femoral PNA, in vitro experiments
were performed. The femur and surrounding musculature was
removed and placed in a dissecting dish containing physiological
saline buffer solution (PSS) at 4uC. The PNA was isolated from the
femur and surrounding muscle tissue by use of a stereomicroscope
as previously described [21,22]. Briefly, the PNA was cannulated
onto glass micropipettes, secured with 11-0 nylon microfilament
suture (Alcon), and the vessel chamber placed under an inverted
microscope (Olympus IX70) equipped with a video camera
(Panasonic BP310), video caliper (307A horizontal video caliper,
Colorado Video), and data-acquisition system (PowerLab) for the
measurement of intraluminal diameter. The PNAs were pressur-
ized to 44 mmHg (60 cmH2O) with two hydrostatic pressure
reservoirs. This intravascular pressure was selected based on
previously reported intravascular pressures of 4361.8 mmHg and
4662.6 mmHg in skeletal muscle resistance arteries of similar size
to the PNA in normotensive rats [28]. PNAs were then checked for
leaks, and those that were leak free were warmed to 37uC and
allowed to develop spontaneous baseline tone ($1 h). Vessels that
leaked or did not develop at least 20% spontaneous tone were
discarded.
Evaluation of Endothelium-Dependent Vasodilator
Responses
Endothelium-dependent vasodilation was assessed by the
cumulative addition of acetylcholine (ACh; 1029–1024 M) to the
Table 1. Tissue and principal nutrient artery (PNA) characteristics in young and old intact, OVX, and OVX+E2 rats.
Intact Young Intact Old OVX Young OVX Old OVX+E2 Young OVX+E2 Old
n 10 11 10 9 11 10
Body mass (g) 21163 31665a 25466b 324620a 22465c 26669abc
Uterine mass (mg) 644653 508624a 144633b 386626ab 339640bc 728677abc
Uterine:body mass ratio (mg/g) 3.060.3 1.660.1a 0.560.1b 1.260.1a 1.560.2bc 2.860.3abc
PNA maximum diamter (mm) 15467 167611 158613 155611 18369bc 18763bc
PNA spontaneous tone (%) 4766 3964 3564 3765 3364 3463
aIndicates significant age-related difference vs. young of same condition.
bIndicates significant difference vs. age-matched intact.
cIndicates significant OVX-E2 difference vs. age-matched OVX (P#0.05).
‘‘n’’ indicates number of animals. Values are mean 6 SE.
doi:10.1371/journal.pone.0048564.t001
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bathing medium. Prior to each concentration-response protocol,
the PNAs developed spontaneous tone. After completion of the
experimental protocols, the maximal diameters of the PNAs were
determined subsequent to a 30-minute incubation period in
calcium-free PSS buffer.
Evaluation of Endothelium Signaling Pathways
PNAs were cannulated and allowed to develop spontaneous
tone. Vasodilation to ACh was evaluated after a 20-min
incubation with one of the following: 1) PSS buffer alone, 2)
PSS buffer containing the nitric oxide synthase (NOS) inhibitor
NG-nitro-L-arginine methyl ester (L-NAME, 1025 M), 3) PSS
buffer containing L-NAME (1025 M) plus the cyclooxygenase
(COX) inhibitor indomethacin (Indo; 1025 M) [21,22,29,30].
Evaluation of Endothelium-Independent Vasodilator
Responses
Endothelium-independent vasodilation was assessed by the
cumulative addition of DEA NONOate (DEA; 1029–1024 M) to
the bathing medium. Prior to each concentration-response
protocol, the PNAs developed spontaneous tone. After completion
of the experimental protocols, the maximal diameters of the PNAs
were determined subsequent to a 30-minute incubation period in
calcium-free PSS buffer.
Determination of Trabecular Bone Volume
Trabecular bone volume of the distal femur metaphysis was
assessed using microcomputed tomography (microCT; Skyscan
1172) as previously described [21]. Femora were wrapped in
parafilm to prevent drying during the scanning. Scans were
obtained using an x-ray source, set at 60 kV and 167 mA over an
angular range of 180 degrees (rotational steps of 0.40 degrees) with
a 12-mm pixel size. Projection images were reconstructed using
standard Skyscan software. The trabecular bone compartment was
segmented from the cortical shell for 50 slices in a region ,0.5-
mm proximal to the most proximal portion of the growth plate for
each animal. Images were binarized (threshold of 100–255) and
trabecular bone volume/tissue volume (BV/TV) was assessed.
Solutions and drugs
Stock solutions were prepared in distilled water; whereby ACh
was frozen at 220uC and serial dilutions of the ACh stock solution
were prepared daily. Serial dilutions of DEA NONOate were
prepared fresh as needed. Serial dilutions of the stock solutions
were prepared daily. All drugs were purchased from Sigma
Chemical (St. Louis, MO).
Statistical Analysis
Vasodilator responses were expressed as a percentage of
maximal relaxation according to the following formula:
Vasodilation %ð Þ~ Ds{Dbð Þ= Dm{Dbð Þ|100
where Dm is the maximal inner diameter recorded at 60 cmH2O
in calcium-free PSS, Ds is the steady-state inner diameter recorded
after each addition of the vasodilator substance, and Db is the
initial baseline inner diameter recorded immediately prior to the
first addition of ACh. One-way ANOVAs were used to determine
the significance of differences in body mass, uterine mass,
uterine:body mass ratio, plasma estrogen concentration, and
spontaneous tone and maximal diameter of the PNAs. Repeated
measures ANOVAs with pairwise comparisons were used to
determine the significance of differences among age and within
factors for vasodilator responses. To examine the relation between
peak endothelium-dependent vasodilation and trabecular bone
volume according to age and estrogen status, linear regression
analyses were measured in young and old rats. In addition,
regression analyses were performed examining the relations
between trabecular bone volume and plasma estrogen, uterine
mass, and peak vasodilation in old and old OVX rats. All data are
presented as mean 6 S.E. Significance was defined as P#0.05.
Results
Animal and PNA Characteristics
Body mass (Table 1) was higher in old vs. young intact animals.
Body mass was greater in young OVX vs. young intact, and
OVX+E2 decreased body mass in both young and old animals
compared to age-matched OVX groups. In addition, body mass
was lower in old OVX+E2 than in old intact animals.
Plasma estrogen concentration for some of the animals in the
old intact (5 out of 11), young OVX (1 out of 10) and old OVX (5
out of 9) groups was below the detectable range (5 pg/ml) for the
ELISA immunoassay technique used to measure estrogen levels.
Therefore, the estrogen concentrations reported for these three
groups are an overestimate of the actual levels because estrogen
values for these animals could not be included in the analysis. For
this reason, we provide median and range values, as well as report
uterine mass as a surrogate marker for estrogen concentration.
Plasma estrogen concentration in young intact animals (median
62 pg/ml; range 26–103 pg/ml) was greater than that in old intact
rats (median 25 pg/ml; range 18–36 pg/ml). OVX decreased
plasma estrogen in young rats (median 22 pg/ml; range 6–32 pg/
ml), but did not alter estrogen levels in old rats (median 34 pg/ml;
range 18–49 pg/ml). In young animals OVX+E2 increased
plasma estrogen (median 40 pg/ml; range 35–54 pg/ml) above
that in the young OVX group and to a level similar of that in the
young intact group. In the old rats OVX+E2 increased plasma
estrogen concentration (median 51 pg/ml; range 31–78 pg/ml) to
levels above that in both the old intact and OVX groups. Uterine
mass (Table 1) was lower in old intact vs. young intact rats. OVX
decreased uterine mass in both age groups relative to age-matched
Figure 1. The effects of age, nitric oxide synthase inhibition with L-NAME and combined nitric oxide synthase and cyclooxygenase
inhibition (L-NAME & Indo) on vasodilator responses of the PNA to increasing doses of the endothelium-dependent vasodilator
acetylcholine. The PNA responses are determined in young and old A) intact, B) ovariectomized (OVX), and C) ovariectomized and estrogen
replaced (OVX+E2) female rats. A. There was an age-related difference in vasodilator responses between young and old INTACT female rats. Blockade
with L-NAME significantly reduced vasodilation in both groups (P,0.05) and abolished the age-related difference in the vasodilator response. The
combined blockade with L-NAME and Indo further reduced PNA vasodilation in the young rats (P,0.05). B. There were no differences in the
vasodilator response between young and old OVX rats under any of the three conditions. Blockade with L-NAME significantly reduced vasodilation in
both groups (P,0.05), and the combined blockade further diminished vasodilation in both OVX groups (P,0.05). C. There were no differences in
vasodilator responses between young and old OVX+E2 rats under any of the three conditions. Inhibition with L-NAME significantly reduced
vasodilation in both groups (P,0.05), whereas the combined L-NAME & Indo blockade had no further effect than L-NAME alone. Values are means 6
S.E; n=9–11 animals per group. *Indicates the vasodilator response is significantly different between groups (P,0.05).
doi:10.1371/journal.pone.0048564.g001
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animals. OVX+E2 elevated uterine mass in both age groups
relative to age-matched OVX rats. Uterine mass was also greater
in old OVX+E2 than in old intact animals, whereas uterine mass
was lower in young OVX+E2 relative to young intact. Age and
condition effects on uterine:body mass ratio were similar to those
of uterine mass (Table 1).
Spontaneous tone of the PNA did not differ among groups
(Table 1). However, PNA maximal diameters in young and old
OVX+E2 were significantly greater than that of age-matched
intact and OVX PNAs (Table 1).
Endothelium-Dependent Vasodilator Responses
ACh-induced vasodilation of the femoral PNA was lower in old
intact relative to that in young intact (Fig. 1A). Inhibition of the
NOS pathway with L-NAME abolished differences in vasodilation
between the two age groups (Fig. 1A). The combined inhibition of
the NOS and COX pathways further lowered vasodilation of
PNAs from young rats, and there remained no aging differences
(Fig. 1A).
Ovariectomy eliminated the old age-related difference in PNA
vasodilation (Fig. 1B) that was evidenced between young and old
intact animals. L-NAME lowered vasodilator responses in PNAs
from both young and old OVX rats, indicating that most of the
vasodilator response occurred through the NOS signaling
mechanism. The combination of L-NAME and Indo abolished
all vasodilation in the PNA of OVX animals (Fig. 1B). Ovariec-
tomy with estrogen replacement also showed no age-related
difference in vasodilation between young and old rats (Fig. 1C).
NOS inhibition lowered endothelium-dependent vasodilator
responses in OVX+E2 rats, whereas the addition of the COX
inhibitor Indo had little further effect in PNAs from both young
and old rats (Fig. 1C).
In young rats, the lowering of estrogen levels with OVX lowered
endothelium-dependent vasodilation, whereas estrogen repletion
in OVX+E2 rats restored vasodilation to levels equivalent to that
in young intact rats (Fig. 2A). In PNAs from old rats, OVX had no
effect on endothelium-dependent vasodilator responses (Fig. 3A).
The chronic addition of exogenous estrogen elevated vasodilation
of PNAs from old rats (Fig. 3A) to levels that were similar to those
in young animals (Fig. 1C).
DEA NONOate Vasodilator Responses
Vasodilation to the direct NO donor DEA NONOate was not
different among groups (Fig. 4), indicating differences in ACh-
induced vasodilation were mediated through the PNA endothelial
cells and not differences in the responsiveness of the smooth
muscle cells.
Trabecular Bone Volume
In young rats, the lowering of plasma estrogen concentration
through OVX reduced trabecular bone volume (BV/TV) by 43%
compared to young intact (Fig. 2B). Estrogen replacement in
OVX+E2 rats increased bone volume to levels similar to those in
young intact rats (Fig. 2B). OVX in old rats had no effect on
trabecular bone volume (Fig. 3B). However, the addition of
exogenous estrogen resulted in 28% higher trabecular bone
volume compared to controls (Fig. 3B).
Regression Analyses
Trabecular bone volume was significantly correlated to peak
vasodilation in both young and old rats (Fig. 2C and 3C) whereby
regression analyses indicated R2 values of 0.641 and 0.671 in
young and old rats, respectively. In addition, in rats with low
estrogen status (i.e., young OVX, old intact and old OVX), there
was no relation between trabecular bone volume and plasma
estrogen (Figs. 5A and 6A) or uterine mass (Figs. 5B and 6B).
However, these groups displayed a significant relation between
peak endothelium-dependent vasodilation and trabecular bone
volume (Figs. 5C and 6C).
Discussion
The purpose of this study was to determine whether estrogen
status affects endothelium-dependent vasodilation in the femoral
diaphyseal principal nutrient artery, and whether these putative
changes in vascular endothelial function are associated with
alterations in trabecular bone volume. In young rats, the results
demonstrate that lowering circulating estrogen through ovariec-
tomy impairs endothelium-dependent vasodilation (Fig. 2A) and
diminishes trabecular bone volume in the femur (Fig. 2B), whereas
replacement of estrogen following ovariectomy maintains both
endothelium-mediated vasodilation and trabecular bone volume.
In old rats, ovariectomy had no effect on circulating estrogen
levels, endothelium-dependent vasodilation (Fig. 3A) or trabecular
bone volume (Fig. 3B). However, the addition of exogenous
estrogen following ovariectomy elevated endothelium-dependent
vasodilation (Fig. 3A) and increased bone volume (Fig. 3B). The
estrogen-induced alterations in endothelium-mediated vasodila-
tion were strongly correlated with changes in trabecular bone
volume in both young (Fig. 2C) and old (Fig. 3C) rats. To our
knowledge, these are the first data to report the effects of
ovariectomy and estrogen replacement on endothelium-dependent
vasodilation in bone from young and old animals, and the first to
examine the relation between vascular function and bone
properties with age and estrogen status as variables.
It has long been appreciated that estrogen can have positive
effects on the skeletal system. For example, during adolescent
growth estrogen is the critical reproductive factor for both girls and
boys [31]. Additionally, a fall in estrogen concentration below
30 pg/mL during menopause corresponds to the period of
accelerated bone loss [31]. The loss of estrogen following
menopause creates an imbalance between bone resorption and
formation that leads to a net loss of bone [32]. Many
postmenopausal women exhibit reduced bone mass as well as
high-turnover bone metabolism, and the reversal of these
conditions are observed following estrogen replacement [33].
The preservation of bone mass during this period requires
Figure 2. The effects of ovariectomy and estrogen replacement on PNA endothelium-dependent vasodilation and trabecular bone
volume in the femur of young rats. A) acetylcholine-induced vasodilation of the PNA, B) trabecular bone volume (BV/TV) of the distal femur, and
C) the relation between peak endothelium-dependent vasodilation (%) and trabecular bone volume (%) in young intact, ovariectomized (OVX), and
ovariectomized and estrogen replaced (OVX+E2) rats. A. Vasodilation was significantly lower in OVX rats, while estrogen replacement (OVX+E2)
maintained vasodilator function to levels similar to that in intact animals. *Indicates the vasodilator response is significantly different between
indicated groups (P,0.05). B. Ovariectomy significantly reduced BV/TV vs. young intact rats, and OVX+E2 maintained trabecular bone volume (BV/TV)
to levels equivalent to that of intact animals. *Indicates a significant difference from intact controls; {indicates a significant difference from OVX rats.
C. Regression analysis indicates a linear relation between peak endothelium-dependent vasodilation (%) and trabecular bone volume (%) of the distal
femur (P,0.001). Values are means 6 S.E; n= 9–11 animals per group.
doi:10.1371/journal.pone.0048564.g002
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Figure 3. The effects of ovariectomy and estrogen replacement on PNA endothelium-dependent vasodilation and trabecular bone
volume in the femur of old rats. A) acetylcholine-induced vasodilation of the PNA, B) trabecular bone volume (BV/TV) of the distal femur, and C)
the relation between peak endothelium-dependent vasodilation (%) and trabecular bone volume (%) in old intact, ovariectomized (OVX), and
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exogenous administration of estrogen sufficient to raise plasma
concentrations to 50 pg/mL [31]. Estrogen receptors are present
on osteoblasts [34,35], but the actions of estrogen on these cells
and osteoblast-like cells have been variable [4]. A recent study
suggests that the mechanism(s) of action of estrogen on bone cell
activity is related to the control of function and lifespan of
osteoclasts, which serves to ultimately minimize bone resorption
[33]. The exact mechanism(s) through which estrogen acts to
modulate bone cell activity is not completely understood, allowing
for the possibility that non-skeletal tissue may act to modulate
bone cell activity [31]. We hypothesize that one such mechanism is
related to bone vascular endothelial function and its ability to 1)
directly influence bone cell activity through local release of
endothelium-derived signaling molecules such as NO and PGI2
[36,37], and 2) to regulate skeletal perfusion, which could
indirectly affect bone cell activity through its impact on fluid
filtration out of the vascular compartment and, correspondingly,
interstitial fluid pressure in bone [13,37–40].
There is a growing body of literature that supports the notion
that the bone vasculature can modulate bone cell activity [40–42].
In regard to old age-related bone loss, previous studies in humans
and animals have shown compromised bone and marrow blood
flow are associated with osteopenia [18–22] and studies in male
rats have shown impaired bone vascular endothelial function is
related to old age-induced bone loss [21,22]. Additionally, a recent
study has reported that a program of low-intensity endurance
exercise training that elicits low mechanical strain on bone restores
endothelial NO-mediated vasodilation of the PNA and increases
trabecular bone volume and mineral density in the distal femur of
old male rats [21]. The results demonstrated that old age-induced
decrements and training-induced enhancement of NO-mediated
vasodilation of the bone vasculature are positively correlated with
changes in the bone properties [21,22].
Results from the present study also demonstrate an association
between NO-mediated vasodilation of bone arteries and trabec-
ular bone volume when estrogen status is altered through
ovariectomy and estrogen replacement (Fig. 2C and 3C). Although
these findings are consistent with the general hypothesis that bone
vascular endothelial function is coupled to bone remodeling
activity, these results alone are inconclusive since estrogen may
have direct effects on both the bone vasculature and bone cell
activity, which could be independent of each other. Therefore, we
sought to determine whether a relation exists between vascular
endothelial function and bone volume in animals where estrogen
concentration was low, i.e., the young OVX and the old intact and
OVX groups. Regression analyses indicated that there were no
relations (P.0.05) between trabecular bone volume and plasma
estrogen (Figs. 5A and 6A) or uterine mass (Figs. 5B and 6B), a
biomarker for reproductive hormone status, indicating that the
direct effects of estrogen on cancellous bone volume are negligible
ovariectomized and estrogen replaced (OVX+E2) rats. A. Vasodilation was not different between old intact control and old OVX rats, while estrogen
replacement (OVX+E2) elevated endothelium-dependent vasodilation to levels above that of intact and OVX animals. *Indicates the vasodilator
response is significantly different between indicated groups (P,0.05). B. Ovariectomy had no effect on BV/TV vs. old intact rats, whereas OVX+E2
elevated trabecular bone volume (BV/TV). *Indicates a significant difference from intact controls; {indicates a significant difference from OVX rats. C.
Regression analysis indicates a linear relation between peak endothelium-dependent vasodilation (%) and trabecular bone volume (%) of the distal
femur (P,0.001). Values are means 6 S.E; n= 9–11 animals per group.
doi:10.1371/journal.pone.0048564.g003
Figure 4. Effects of age, ovariectomy (OVX), and ovariectomy and estrogen replaced (OVX+E2) on vasodilator responses of the PNA
to increasing doses of the endothelium-independent, direct NO donor DEA NONOate in female rats. Responses were not different
among groups. Values are means 6 S.E; n=9–11 animals per group.
doi:10.1371/journal.pone.0048564.g004
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in these low-estrogen groups. However, there was a significant
association between peak endothelium-dependent vasodilation
and trabecular bone volume (Figs. 5C and 6C) in the femur.
These findings provide support for the concept of a vascular
coupling mechanism in bone. This conclusion of a coupling
mechanism between the bone vasculature and bone mass is further
supported by two studies in humans, where forearm conduit artery
endothelial vasodilator responsiveness, used as a surrogate
measure of bone endothelial function, was positively correlated
with lumbar spine bone mineral density in postmenopausal
women [43,44]. Thus, in groups without the potentially
confounding influence of estrogen, the relation between endothe-
lial function and bone mass is still evident.
Intact young and old female rats regulate vasodilation of the
femoral PNA primarily through a NOS signaling mechanism and
to a lesser extent through a COX signaling pathway (Fig. 1A).
These regulatory mechanisms are similar to those of male animals,
whereby endothelium-dependent vasodilation is mediated pre-
dominantly via the NOS signaling cascade [21,22]. The old age-
associated decrement in endothelium-dependent vasodilation in
female rats results from declines in NO-mediated regulation,
which is also similar to that observed in male rats. In the absence
of estrogen (OVX group), vasodilation in the presence of L-
NAME alone is eliminated (Fig. 1B). Interestingly, with estrogen
replacement the regulating vasodilator mechanism shifts from the
primarily NO signaling pathway to one that includes NO and the
putative endothelium-derived hyperpolarizing factor, as indicated
by the significant vasodilation that occurs in estrogen replete rats
when both NOS and COX signaling pathways are blocked
(Fig. 1C). Therefore, the addition of estrogen from an exogenous
source does not simply restore the regulatory mechanisms for
vasodilation but alters the signaling mechanisms through which
the peak endothelium-dependent vasodilation of the bone
resistance vasculature is achieved. A shift in the mechanism of
endothelium-dependent vasodilation with OVX has also been
reported in mesenteric arteries. In intact rats, endothelium-
dependent vasodilation of mesenteric arteries is mediated through
both the NOS and COX signaling pathways; OVX diminished
the NO-mediated component and augmented the contribution of
the COX signaling pathway [45].
The decrement in endothelium-dependent vasodilation of the
femoral PNA with OVX in young rats has also been reported to
occur in other vascular beds. For example, OVX has been shown
to depress endothelium-dependent vasodilation of pulmonary
arteries [46], the thoracic aorta [46], and coronary resistance
arteries [26] in young rats. However, several studies examining the
effects of OVX on endothelium-dependent vasodilation in bone
arteries of young animals have reported results that are dissimilar
to those of the present investigation. In the first study, arterial
segments from rabbits were isolated from the metaphyseal
cancellous bone and the diaphyseal bone marrow of the femur
six weeks after OVX [47]. The vessel segments with a diameter of
,250 mm were cut into rings and two 40 mm diameter steel wires
were passed through the lumen of the vessel rings. Changes in
isometric force were measured with increasing concentrations of
ACh after the arterial rings were preconstricted with norepineph-
rine. The results indicated that OVX did not alter endothelium-
dependent relaxation [47]. The disparity of results compared to
the current study could be due to several factors, including
differences in 1) the animal species studied and 2) the techniques
employed to study the vascular responses. For instance, unlike rats
and humans, rabbits do not undergo the various stages of the
estrous cycle [48]. Also, the wire myograph technique used is not
ideal for determination of endothelium-dependent vasodilation in
small diameter vessels because of the potential for the wires to
damage endothelial cells as they are passed through the lumen of
the vessel rings.
The second study with disparate results relative to those of the
current study investigated the effects of OVX in medullary
Figure 5. Scattergrams showing the relation between plasma
estrogen, uterine mass and endothelium-dependent vasodila-
tion on trabecular bone volume (BV/TV) in the distal femur of
young ovariectomized rats. A) plasma estrogen concentration from
animals with estrogen levels within the detectable range; B) uterine
mass, a biomarker for reproductive hormone concentration ovariecto-
mized; and C) peak endothelium-dependent vasodilation of the femoral
PNA. BV/TV was not related to either plasma estrogen (A) or uterine
mass (B) in this group, whereas a significant (P,0.001) linear relation
exists between BV/TV and percent PNA vasodilation (C).
doi:10.1371/journal.pone.0048564.g005
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Figure 6. Scattergrams showing the relation between plasma estrogen, uterine mass and endothelium-dependent vasodilation on
trabecular bone volume (BV/TV) in the distal femur of old intact and ovariectomized rats. A) plasma estrogen concentration from animals
with estrogen levels within the detectable range; B) uterine mass, a biomarker for reproductive hormone concentration; and C) peak endothelium-
dependent vasodilation of the femoral PNA. BV/TV was not related to either plasma estrogen (A) or uterine mass (B) in these groups, whereas a
significant (P,0.001) linear relation exists between BV/TV and percent PNA vasodilation (C).
doi:10.1371/journal.pone.0048564.g006
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arterioles from the femur of rats using the pressurized vessel
technique [49]. Vasodilation induced by ACh was not different
between medullary arterioles from intact and OVX rats. The
discrepancy in findings may result from differences in the strain of
rat studied (Fischer-344 vs. Sprague Dawley), age of the animals at
sacrifice (6 and 24 months vs. 3 to 3 K months) and, most
probably, differences in the period of OVX (2 months vs. 7–10
days).
Few studies have examined the effects of OVX on endothelium-
dependent vasodilation with advanced age. Castillo et al. [50]
reported that relaxation of aortic rings to ACh was reduced in 20-
month-old OVX rats. In contrast, OVX had no further effect to
depress endothelium-dependent vasodilation of coronary resis-
tance arteries [26] and femoral PNAs (present study) from old rats.
These results indicate that the old age-associated decline in
circulating estrogen may contribute to the overall reduction in
endothelial cell vasodilator responsiveness that occurs with
advancing age [21,22,27,29].
The lack of bone loss with ovariectomy in the aged animals was
counterintuitive to anticipated results and other published reports.
For example, ovariectomy in rats 18 months of age has shown
volume decrements in long bones as well as the vertebrae [51–53].
However, to our knowledge, there are no published reports on
bone responses to ovariectomy utilizing rats of such an advanced
age (i.e., 24 months) as the current investigation.
In conclusion, the results of the present study demonstrate that
lowering circulating estrogen through ovariectomy impairs endo-
thelium-dependent vasodilation (Fig. 2A) and diminishes trabec-
ular bone volume (Fig. 2B) in the femur of young, but not in old
female rats (Figs. 3A and 3B). Estrogen replacement following
ovariectomy maintains and enhances both endothelium-mediated
vasodilation and trabecular bone volume in young and old
animals, respectively. The estrogen-induced alterations in endo-
thelium-mediated vasodilation were strongly correlated with
changes in trabecular bone volume in both young (Fig. 2C) and
old (Fig. 3C) rats, indicating a possible coupling mechanism
between the vascular endothelium and bone remodeling activity.
Unfortunately, these results alone are inconclusive due to the fact
that estrogen may have direct effects on both the bone vasculature
and bone cell activity that are independent of each other.
However, in young OVX and old intact and OVX animals,
where circulating estrogen levels are low with negligible effects on
cancellous bone volume (Figs. 5A, 5B, 6A and 6B), regression
analysis demonstrated a significant relation between peak endo-
thelium-dependent vasodilation and trabecular bone volume
(Figs. 5C and 6C) in the femur. These results provide support
for a mechanism coupling vascular endothelial vasodilator
signaling with bone volume.
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